PE20071225A1 - Compuestos derivados de piperidina como inhibidores de neurocinina-1 (nk-1) y del transportador de serotonina - Google Patents

Compuestos derivados de piperidina como inhibidores de neurocinina-1 (nk-1) y del transportador de serotonina

Info

Publication number
PE20071225A1
PE20071225A1 PE2007000467A PE2007000467A PE20071225A1 PE 20071225 A1 PE20071225 A1 PE 20071225A1 PE 2007000467 A PE2007000467 A PE 2007000467A PE 2007000467 A PE2007000467 A PE 2007000467A PE 20071225 A1 PE20071225 A1 PE 20071225A1
Authority
PE
Peru
Prior art keywords
alkyl
phenyl
methyl
neurocinin
piperidine
Prior art date
Application number
PE2007000467A
Other languages
English (en)
Inventor
Andrew P Degnan
George Tora
Ying Han
Ramkumar Rajamani
Derek J Denhart
Jonathan L Ditta
Kevin W Gillman
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of PE20071225A1 publication Critical patent/PE20071225A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Diabetes (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

SE REFIERE A COMPUESTOS DERIVADOS DE PIPERIDINA DE FORMULA (I) DONDE R1 ES H, ALQUILO(C1-C6), CICLOALQUILO(C3-C7) O BENCILO; R2 ES H O ALQUILO(C1-C6); R3 ES H O ALQUILO(C1-C6); R4 ES H, ALQUILO(C1-C6), HALOALQUILO(C1-C6), CN, ENTRE OTROS; R5 ES H, ALQUILO(C1-C6), HALOALQUILO(C1-C6), HIDROXI, ENTRE OTROS; Ar1 ES FENILO O PIRIDINILO SUSTITUIDO CON HALO, ALQUILO(C1-C6), HALOALQUILO(C1-C6), CN, FENILO O FURANILO; Ar2 ES FENILO, NAFTILO, FURANILO, ENTRE OTROS, SUSTITUIDOS CON HALO, ALQUILO(C1-C6), CN, NITRO, ENTRE OTROS SUSTITUYENTES. SON COMPUESTOS PREFERIDOS: 2-METOXI-5-(3-(((4-FENILPIPERIDIN-4-IL)METOXI)METIL)-5-(TRIFLUOROMETIL)FENIL)PIRIMIDINA, 4-(5-(3-(((4-FENILPIPERIDIN-4-IL)METOXI)METIL)-5-(TRIFLUOROMETIL)FENIL)PIRIDIN-2-IL)MORFOLINA, 3-METIL-4-(3-(((4-FENILPIPERIDIN-4-IL)METOXI)METIL)-5-(TRIFLUOROMETIL)FENIL)PIRIDINA, ENTRE OTROS. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON INHIBIDORES DE NEUROCININA-1 (NK-1) Y DEL TRANSPORTADOR DE SEROTONINA SIENDO UTILES EN EL TRATAMIENTO DE ESQUIZOFRENIA, DEMENCIA, ASMA, RINITIS
PE2007000467A 2006-04-17 2007-04-17 Compuestos derivados de piperidina como inhibidores de neurocinina-1 (nk-1) y del transportador de serotonina PE20071225A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79260406P 2006-04-17 2006-04-17
US11/734,809 US20070249607A1 (en) 2006-04-17 2007-04-13 Nk-1 and serotonin transporter inhibitors

Publications (1)

Publication Number Publication Date
PE20071225A1 true PE20071225A1 (es) 2008-01-14

Family

ID=38510473

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2007000467A PE20071225A1 (es) 2006-04-17 2007-04-17 Compuestos derivados de piperidina como inhibidores de neurocinina-1 (nk-1) y del transportador de serotonina

Country Status (5)

Country Link
US (2) US20070249607A1 (es)
AR (1) AR060496A1 (es)
PE (1) PE20071225A1 (es)
TW (1) TW200811135A (es)
WO (1) WO2007121389A2 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8071778B2 (en) * 2006-07-27 2011-12-06 Bristol-Myers Squibb Company Substituted heterocyclic ethers and their use in CNS disorders
JP2009544726A (ja) * 2006-07-27 2009-12-17 ブリストル−マイヤーズ スクイブ カンパニー 置換ヘテロサイクリックエーテルおよびｃｎｓ疾患におけるその使用
US7858666B2 (en) 2007-06-08 2010-12-28 Mannkind Corporation IRE-1α inhibitors
US8026257B2 (en) * 2007-07-11 2011-09-27 Bristol-Myers Squibb Company Substituted heterocyclic ethers and their use in CNS disorders
US20090018163A1 (en) * 2007-07-11 2009-01-15 Bristol-Myers Squibb Company Substituted Heterocyclic Ethers and Their Use in CNS Disorders
US7632861B2 (en) * 2007-11-13 2009-12-15 Bristol-Myers Squibb Company Substituted heterocyclic ethers and their use in CNS disorders
WO2009096941A1 (en) * 2008-01-28 2009-08-06 Bristol-Myers Squibb Company Substituted heterocyclic ethers and their use in cns disorders
CA2742105C (en) * 2008-11-14 2016-09-13 Theravance, Inc. 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
BR112019018774A2 (pt) * 2017-03-12 2020-04-07 Wang Xiaodong composto tendo uma estrutura de acordo com a fórmula i, sal farmaceuticamente aceitável, composição farmacêutica, método para prevenir ou tratar uma doença ou afeção e método para imunomodulação, inibição ou prevenção de rejeição de enxertos de órgãos ou pele ou tratamento de tumores ou câncer

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1337418C (en) 1988-03-28 1995-10-24 Engelbert Ciganek 4-aryl-4-piperiding (or pyrrolidine or hexahydroazepine) carbinols and heterocyclic analogs thereof
ATE188472T1 (de) * 1992-10-28 2000-01-15 Merck Sharp & Dohme 4-arylmethyloxymethyl piperidine als tachykinin antagonisten
DE69504300T2 (de) * 1994-01-13 1999-04-29 Merck Sharp & Dohme Ltd., Hoddesdon, Hertfordshire Gem-bissubstituierte azazyclische tachykinin-antagonisten
AU2003220215B2 (en) 2002-03-13 2007-01-04 Schering Corporation NK1 antagonists
ES2285151T3 (es) 2002-07-03 2007-11-16 Schering Corporation Derivados de 1-amido-4-fenil-4-benciloximetil-piperidina y compuestos relacionados como antagonistas de neurocinina-1 (nk-1) para el tratamiento de vomitos, depresion ansiedad y tos.
EP1546101A1 (en) 2002-09-09 2005-06-29 AstraZeneca AB Naphthyl ether compounds and their use
US7276631B2 (en) * 2004-07-20 2007-10-02 Bristol-Myers Squibb Company Cyclopentylamine and cyclohexylamine derivatives as NK-1/SSRI antagonists
US7138423B2 (en) * 2004-07-20 2006-11-21 Bristol-Myers Squibb Company Arylpyrrolidine derivatives as NK-1 /SSRI antagonists
US7494986B2 (en) * 2004-07-20 2009-02-24 Bristol-Myers Squibb Company Cycloalkylamine derivatives as NK-1/SSRI antagonists
US7098203B2 (en) * 2004-07-20 2006-08-29 Bristol-Myers Squibb Company Homopiperidine derivatives as NK-1 antagonists

Also Published As

Publication number Publication date
US8383821B2 (en) 2013-02-26
US20100087434A1 (en) 2010-04-08
AR060496A1 (es) 2008-06-18
TW200811135A (en) 2008-03-01
US20070249607A1 (en) 2007-10-25
WO2007121389A2 (en) 2007-10-25
WO2007121389A3 (en) 2008-02-21

Similar Documents

Publication Publication Date Title
PE20071225A1 (es) Compuestos derivados de piperidina como inhibidores de neurocinina-1 (nk-1) y del transportador de serotonina
PE20191757A1 (es) Compuestos heterociclicos utiles como inhibidores dobles de atx/ca
PE20141681A1 (es) Inhibidores de btk
PE20090717A1 (es) Derivados de quinolina como inhibidores de la pi3 quinasa
PE20081836A1 (es) Derivados de piperidina como inhibidores de la sintasa de acido graso
NZ588652A (en) Carboxamide compounds for the treatment of metabolic disorders
PE20070795A1 (es) Compuestos pirazol-urea-heterociclicos como inhibidores de cinasa
PE20090895A1 (es) Derivados de triazol como inhibidores de la jak quinasa
PE20090290A1 (es) Derivados de pirrolopiridina como inhibidores de bace
PE20090288A1 (es) Derivados de quinoxalina como inhibidores de la pi3 quinasa
PE20141375A1 (es) Activadores de glucoquinasa
EA201000561A1 (ru) Производные пиридина, пригодные в качестве активаторов глюкокиназы
AR059249A1 (es) Compuesto amina trisustituido
CL2012001171A1 (es) Procedimiento para la preparacion del ester n-[[2-[[[4-[[[(hexiloxicarbonil)]4-amino]iminometil]fenil]amino]metil]1-alquil-1h-benzimidazol-5-il]carbonil]n-2-piridinil-etilico de beta-alanina; y uno de los compuestos intermediarios considerados.
PE20142099A1 (es) Derivados de sulfonamida
PE20090974A1 (es) Mezclas fungicidas
PE20091656A1 (es) Compuestos heterociclicos como inhibidores de la cinasa raf
PE20120321A1 (es) Indazoles sustituidos con oxazol como inhibidores de pi3-quinasa
PE20091653A1 (es) Derivados sustituidos de pirazol y su uso
PE20141120A1 (es) Compuestos heterociclicos
PE20120690A1 (es) Derivados de 5-fluoropirimidinona
PE20091573A1 (es) Derivados heterociclicos de urea como inhibidores de adn girasa y/o topoisomerasa
PE20081404A1 (es) Derivados de sulfonil-fenil-2h-[1,2,4]oxadiazol-5-ona y procesos para su preparacion
PE20130774A1 (es) Compuestos heterociclicos activadores de ampk y metodos para emplearlos
PE20140207A1 (es) Composiciones y metodos para modular el fxr

Legal Events

Date Code Title Description
FC Refusal